A new drug developed by QIMR Berghofer could transform the treatment of COVID-19 by potentially protecting against infection by any SARS-CoV-2 variant and reversing the persistent inflammation that is a major driver of debilitating long COVID.

  • Drusas@kbin.social
    link
    fedilink
    English
    arrow-up
    13
    ·
    edit-2
    1 year ago

    It’s worth noting that it is not currently known whether or not reducing inflammation will have a significant impact on long Covid symptoms. Research is still being done in that area.